Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs.

Autor: Erçalışkan A; Division of Hematology, Department of Internal Medicine, and., Seyhan Erdoğan D; Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey., Eşkazan AE; Division of Hematology, Department of Internal Medicine, and.

Publikováno v: Blood advances [Blood Adv] 2021 Sep 14; Vol. 5 (17), pp. 3344-3353.